Efferon vs Ray Therapeutics
Efferon vs Ray Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Efferon is on 45/100 and Ray Therapeutics on 53/100.
Where each one leads
Efferon
- agent readiness: 52/100 against 21/100
Ray Therapeutics
- our overall score: 53/100 against 45/100
- funding raised: $243M against $17.5M
At a glance
| Measure | Efferon | Ray Therapeutics |
|---|---|---|
| What it is | Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Medical Devices, Healthcare, Biotech | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Services |
| Founded | 2017 | 2021 |
| Headquarters | Tel Aviv, Israel | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Efferon | Ray Therapeutics |
|---|---|---|
| Total funding | $17.5M | $243M |
| Latest round | Seed | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Efferon | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 45/100 | 53/100 |
| Traction | 36/100 | 40/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 15/100 | 14/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (52/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Efferon | Ray Therapeutics |
|---|---|---|
| Hosting | Vercel | Not detected |
| CDN | Vercel | Cloudflare |
| CMS | Ghost | WordPress |
| Frameworks | Next.js | Jquery |
| Analytics | Not detected | Google Analytics 4 |
Efferon vs Ray Therapeutics: common questions
Which is better, Efferon or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Efferon and Ray Therapeutics compare on the numbers?
Efferon leads on agent readiness (52/100 against 21/100). Ray Therapeutics leads on our overall score (53/100 against 45/100), funding raised ($243M against $17.5M).
Read the full Efferon review and pricing or the Ray Therapeutics review and pricing. You can also browse other Efferon alternatives we track.